Diabetes, Obesity and Metabolism Center's Betul Hatipolgu discusses study findings linking impulsivity and violent behavior

GLP-1s like Ozempic, Wegovy linked to surprising drop in violent behavior
Healthline: Betul Hatipoglu, director of Case Western Reserve University’s Diabetes, Obesity, and Metabolism Center, discussed a recent study's finding that the link between impulsivity and violent behavior was significantly weaker among current GLP-1 users. She emphasized the drugs do not appear to directly reduce violent crime but may lessen the impact of key violence risk factors, including impulsivity and alcohol use.